Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: BGI; Accelr8 Technology; XDx

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BGI and Xi'an Jiaotong University announced today that they have completed the sequencing of the endangered crested ibis (Nipponia Nippon). They said it is the fourth bird to be sequenced in the world, following the chicken, zebra finch, and turkey, and "has significant value and strategic importance to the protection and rescue of crested ibis from extinction and for the definition of its biological phenomenon." The sequencing effort was part of BGI's 1000 Plant and Animal Reference Genomes Project.


Accelr8 Technology said this week that its option agreement with Novartis Vaccines and Diagnostics extends the exclusivity period for good faith negotiations of business terms for a definitive pact. The extension period now includes milestones related to product development. As reported in February by GenomeWeb Daily News, Novartis is evaluating Accelr8's BACcel system for identifying the type and quantity of bacterial pathogens in clinical specimens through a technology evaluation agreement that has been extended to June 30, 2011.


XDx said this week that its AlloMap test has been CE Marked in the European Union under the In Vitro Diagnostics Directive. XDx received US Food and Drug Administration clearance for AlloMap in 2008. The test is a non-invasive, multi-gene expression assay used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with a standard clinical assessment.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.